CASI Pharmaceuticals Inc (NASDAQ:CASI)

1.59
Delayed Data
As of Jul 27
 -0.035 / -2.15%
Today’s Change
1.07
Today|||52-Week Range
2.13
+19.55%
Year-to-Date
No recent news for CASI Pharmaceuticals Inc.

Today’s Trading

Previous close1.63
Today’s open1.56
Day’s range-- - --
Volume25,061
Average volume (3 months)37,796
Market cap$52.7M
Dividend yield--
Data as of 07/27/2015

Growth & Valuation

Earnings growth (last year)-318.18%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales1,602.89
Price/Book--

Competitors

 Today’s
change
Today’s
% change
EBIOEleven Biotherapeuti...+0.06+2.00%
NVETNexvet Biopharma plc-0.11-2.34%
HTBXHeat Biologics Inc+0.12+1.98%
MEIPMEI Pharma Inc-0.06-3.73%
Data as of 07/27/2015

Financials

Next reporting dateAugust 17, 2015
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$23.7K
Annual profit (last year)-$26.2M
Net profit margin-110,432.45%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ken Keyong Ren
COO, Secretary, Vice President &
General Counsel
Cynthia Wong Hu
Corporate headquarters
Rockville, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers